Cardiac Troponin T (cTnT): A Gold-Standard Biomarker for Myocardial Injury Research

Concept

Cardiac troponin T (cTnT) is a cardiac-specific protein subunit and a core component of the cardiac troponin (cTn) heterotrimeric complex, which also includes troponin I (cTnI) and troponin C (cTnC). Exclusively expressed in cardiomyocytes with distinct isoform characteristics from skeletal muscle troponin, cTnT serves as a highly specific and sensitive biomarker for myocardial injury. Upon myocardial cell damage or necrosis, cTnT is released into the peripheral circulation in specific molecular forms, making it the gold standard for clinical diagnosis, risk stratification, therapeutic monitoring and prognostic evaluation of acute coronary syndrome (ACS) and acute myocardial infarction (AMI), as endorsed by international cardiovascular clinical guidelines.

Research Frontier

Current research on cTnT focuses on its molecular characteristics, release kinetics, diagnostic performance comparison with other cardiac biomarkers, and the expansion of its clinical and research applications. Key research directions include the in-depth analysis of cTnT’s structural and functional properties, the identification of its circulating molecular forms in different myocardial injury scenarios, the comparative evaluation of diagnostic sensitivity and specificity between cTnT and cTnI, and the exploration of cTnT’s value in diagnosing minor myocardial injury, myocarditis and cardiovascular complications of systemic diseases. Additionally, the development of high-sensitivity detection technologies for cTnT and the application of recombinant cTnT protein in the research of cardiac injury mechanisms and diagnostic reagent development have become important research hotspots in cardiovascular biomedicine.Research Significance

In-depth research on cTnT and the development of high-quality cTnT-related research reagents hold profound scientific, clinical and industrial significance for cardiovascular disease research and translational medicine:

1. Clinical diagnostic value: As the gold standard biomarker for myocardial injury, cTnT provides objective and reliable laboratory evidence for the early and accurate diagnosis of AMI and ACS, helping clinicians implement timely and targeted therapeutic strategies and reducing the mortality of cardiovascular acute events.
2. Prognostic and therapeutic monitoring value: Dynamic changes in serum cTnT levels can effectively evaluate the efficacy of thrombolytic therapy and reperfusion in AMI patients, predict short-, medium- and long-term clinical outcomes of ACS patients, and realize personalized risk stratification and therapeutic effect monitoring.
3. Expansion of disease diagnosis scope: cTnT has superior diagnostic sensitivity for minor myocardial injury, perioperative myocardial infarction after cardiac surgery and myocarditis, and can also distinguish myocardial injury from skeletal muscle trauma, providing a specific diagnostic basis for cardiovascular complications of systemic diseases such as renal failure and hypothyroidism.
4. Biomedical research value: cTnT is an important research tool for exploring the molecular mechanism of myocardial injury, evaluating drug-cardiac interactions and developing new anti-cardiovascular disease drugs, laying a foundation for the development of precision cardiovascular medicine.
5. Industrial application value: High-purity recombinant cTnT protein is the core raw material for the development of high-sensitivity cTnT diagnostic reagents (e.g., chemiluminescence, ELISA kits), driving the innovation and upgrading of in vitro diagnostic (IVD) products for cardiovascular diseases.

Related Product Applications

ANT BIO PTE. LTD. provides high-quality recombinant human cTnT protein products through its UA and Starter sub-brands, which are rigorously verified for purity, activity and specificity, and are widely applied in various core research and industrial scenarios of cardiovascular disease research and diagnostic reagent development:

1. Cardiovascular disease mechanism research: Recombinant cTnT protein is used to study the structural and functional characteristics of the cardiac troponin complex, explore the molecular mechanism of myocardial injury-induced cTnT release, and analyze the interaction between cTnT and other myocardial proteins, providing key tools for in-depth understanding of cardiomyocyte contraction and injury mechanisms.
2. Development of cTnT diagnostic reagents: As the core antigen raw material, high-purity cTnT protein is used to develop high-sensitivity and high-specificity cTnT in vitro diagnostic kits (e.g., ELISA, chemiluminescence immunoassays), which is the foundation for the production of clinical cTnT detection reagents.
3. Validation of cTnT detection technologies: Recombinant cTnT protein is used to calibrate cTnT detection platforms, verify the sensitivity and specificity of new detection technologies, and ensure the accuracy and reliability of cTnT detection results in clinical and research settings.
4. Pharmacological research and drug evaluation: cTnT protein is used to evaluate the cardiac toxic effects of new drugs and the protective effects of anti-myocardial injury drugs, providing an objective index for drug-cardiac interaction research and the development of cardiovascular disease therapeutic drugs.
5. Basic research on cardiac biomarkers: Recombinant cTnT protein is used for comparative research with other cardiac biomarkers (e.g., cTnI, CK-MB), analyzing the differences in release kinetics, diagnostic performance and clinical application scope, and providing experimental data for the optimal selection of cardiac injury biomarkers.

In addition, ANT BIO PTE. LTD.’s Absin sub-brand provides a full range of general life science reagents and research kits (e.g., protein detection kits, immunoassay reagents) that complement the cTnT research workflow, supporting the experimental detection and analysis in the whole process of cardiovascular biomarker research.

Related Product List

ANT BIO PTE. LTD. offers high-quality recombinant human cardiac troponin T (cTnT) protein products through its UA and Starter sub-brands, with advanced expression systems and strict quality control to ensure product performance and experimental reliability. The detailed product information is shown in the table below:

For detailed product specifications, sample size and customized service, please contact our professional technical support team for personalized product solutions and technical consultation.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.